- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.04. | CDC panel mulls changes to COVID shot recommendations | ||
| 16.04. | Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents | ||
| 16.04. | Startup Glycomine raises $115M to push rare disease drug deeper into testing | ||
| 15.04. | Health department layoffs may be illegal, experts say | ||
| 15.04. | J&J keeps forecasts steady as pharma confronts tariff threat | ||
| 15.04. | Bristol Myers stumbles in bid to widen heart drug's use | ||
| 15.04. | US launches probe that could set stage for pharma tariffs | ||
| 14.04. | Safety worries spur Pfizer to drop another obesity pill | ||
| 14.04. | Third Harmonic outlines plans for dissolution | ||
| 14.04. | Pharma bosses face down investor angst on tariffs, HHS chaos | ||
| 14.04. | Verve's second swing at gene editing for heart disease shows early promise | ||
| 14.04. | The critical role of evidence-based databases in pharmacogenomics: Ensuring accuracy, consistency and relevance | ||
| 14.04. | Translating FDA guidance into action: Regulatory considerations for orphan drug developers | ||
| 14.04. | Mining the hidden gems in unstructured EMR data | ||
| 11.04. | Amgen says Imdelltra extended survival; Parker Institute adds new leaders | ||
| 11.04. | FDA plans to phase out animal testing for some drugs | ||
| 11.04. | Amid tariff turmoil, Novartis commits to spending $23B on U.S. manufacturing | ||
| 10.04. | Tempest seeks strategic alternatives as cash runs out for Phase 3 trial | ||
| 10.04. | Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts | ||
| 09.04. | Trump pauses most reciprocal tariffs, hikes China's further | ||
| 09.04. | Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division | ||
| 09.04. | Trump says 'major' tariffs coming on pharmaceuticals | ||
| 08.04. | US risks losing biotech edge to China, report warns | ||
| 08.04. | Rallybio discontinues lead drug for rare maternal disorder | ||
| 08.04. | Tango Therapeutics cuts nearly one-fifth of staff |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .